About Devats India Private Limited
Data last updated:
Devats India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 February 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PTC065559. Its GSTIN is 07AABCD4897L1Z4 (Delhi).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹32.16 Lakh. It is led by directors Vatsala Khurana and Vijay Khurana.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House.No.5/18 Second Floor Shanti Niketan, New Delhi, Delhi, India – 110021.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.87 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹94.59 Lakh (net margin 4.8%) and EBITDA of ₹1.61 Cr (EBITDA margin 8.1%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.
The company is associated with 1 brand: DeVats. As per MCA filings, the company has open charges of ₹6.08 Cr and satisfied charges of ₹1.15 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website devats.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressHouse.No.5/18 Second Floor Shanti Niketan, New Delhi, Delhi, India – 110021
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Devats India Private Limited
The main business activities of Devats India are trade and hospital and medical care. In detail, this covers wholesale trading and other hospital and medical care activities. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Devats India Private Limited FY 2025 filings available
Devats India Private Limited reported revenue of ₹19.87 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Devats India Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 7% over three years, including 31% growth in the latest year. EBITDA fell 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Devats India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.61 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹94.59 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Devats India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Devats India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Devats India Private Limited
Devats India Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Formulations, Medical Consumables, Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ashri Medico Surgicals Private Limited | ₹20.03 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Indore, Madhya Pradesh, India |
| Axio Biosolutions Private Limited | ₹19.9 Cr (FY 2024) | •••• | •••• | -17.0% | •••• | Ahmedabad, Gujarat, India |
| Pace Pharmatech Private Limited | ₹19.87 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Mumbai, Maharashtra, India |
| Bion Healthcare Private Limited | ₹19.87 Cr (FY 2025) | •••• | •••• | 5690.0% | •••• | Ahmedabad, Gujarat, India |
| Deluxe Scientific Surgico Private Limited | ₹19.87 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Delhi, India |
| Devats India Private Limited this company | ₹19.87 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | New Delhi, Delhi, India |
| Intellio Healthcare Private Limited | ₹19.87 Cr (FY 2025) | •••• | •••• | 185.0% | •••• | New Delhi, Delhi, India |
| Wadi Surgicals Private Limited | ₹19.84 Cr (FY 2025) | •••• | •••• | 113.0% | •••• | Hyderabad, Telangana, India |
| Arovea Formulations Private Limited | ₹19.82 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Ahmedabad, Gujarat, India |
| Nidek Medical India Private Limited | ₹19.82 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Kolkata, West Bengal, India |
| Bhavani Pharmachem Private Limited | ₹19.81 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Devats India by revenue in the Healthcare industry (Formulations, Medical Consumables, Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Devats India Private Limited
Devats India Private Limited is audited by NANGIA & CO LLP for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NANGIA & CO LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Devats India Private Limited
Devats India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vatsala Khurana | Director | 17 Feb 1995 | 31 Years 7 Months | Current |
| Vijay Khurana | Director | 17 Feb 1995 | 31 Years 7 Months | Current |
Ownership and Shareholding of Devats India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Devats India Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Nov 2019 | Others | ₹2.7 Cr | Open |
| 16 Aug 2018 | Others | ₹91.25 Lakh | Open |
| 20 Mar 2006 | Federal Bank Limited | ₹20 Lakh | Open |
| 20 Mar 2006 | Federal Bank Limited | ₹40 Lakh | Open |
| 20 Mar 2006 | The Federal Bank Ltd. | ₹70 Lakh | Open |
Total charge records: 9 View all charges
Associated Brands with Devats India Private Limited
Devats India operates one associated brand: DeVats. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of pharmaceuticals and medical devices in the healthcare sector. | devats.com |
Employees and EPFO Compliance at Devats India Private Limited
Employment history and EPFO contributions of people linked to Devats India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Devats India Private Limited
Devats India Private Limited has 2 board changes on record since 1995: 2 appointments. The latest: Vatsala Khurana was appointed as Director on 17 Feb 1995.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Devats India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Devats India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Devats India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Devats India Private Limited
Devats India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCD4897L1Z4 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Devats India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Devats India Private Limited
Devats India is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 February 1995 (31+ years old) and is registered under CIN U74899DL1995PTC065559.
Devats India reported revenue of ₹19.87 Cr for FY 2025 (up 31% YoY).
Devats India has 2 current directors:
- Vatsala Khurana - Director
- Vijay Khurana - Director
Devats India reported a net profit of ₹94.59 Lakh (net margin 4.8%) and EBITDA of ₹1.61 Cr (EBITDA margin 8.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Devats India is 7% over three years. In the latest year (FY 2025) revenue rose 31%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Devats India is 07AABCD4897L1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Devats India is U74899DL1995PTC065559. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Devats India was incorporated on 17 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Devats India by revenue are Ashri Medico Surgicals Private Limited, Axio Biosolutions Private Limited, Pace Pharmatech Private Limited, Bion Healthcare Private Limited, Deluxe Scientific Surgico Private Limited and 5 more, all in the Healthcare industry (Formulations, Medical Consumables, Medical and Laboratory Equipment).
Vatsala Khurana was appointed as Director on 17 Feb 1995. Vijay Khurana was appointed as Director on 17 Feb 1995.
Devats India can be reached through the website devats.com. Its registered office is in New Delhi, Delhi, India.